Abstract
The European Respiratory Society accepted 4062 abstracts for presentation at the International Congress in 2020. Though the conference was held virtually making it possible to replay presentations, it remains a challenge to keep abreast of all the clinical and scientific advances. Therefore, this article provides highlights from the General Pneumology Assembly. Selected presentations from rehabilitation and chronic care, general practice and primary care, M-health and E-health are summarised. This review incorporates novel findings from laboratory-based science, randomised controlled trials and qualitative research together with insights from newly available clinical guidelines.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Daines has nothing to disclose.
Conflict of interest: Dr. Buekers reports grants from European Respiratory Society (ERS Long-Term Research Fellowship 2020), other from Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019-2023” Program (CEX2018- 000806-S), other from Generalitat de Catalunya through the CERCA Program, during the conduct of the study.
Conflict of interest: Dr. Kocks reports grants, personal fees and non-financial support from AstraZeneca, grants, personal fees and non-financial support from Boehringer Ingelheim, grants and personal fees from Chiesi Pharmaceuticals, grants, personal fees and non-financial support from GSK, grants and personal fees from Novartis, grants from MundiPharma, grants from TEVA, outside the submitted work; and Janwillem Kocks holds 72.5% of shares in the General Practitioners Research Institute.Dr. Kocks reports grants and non-financial support from AstraZeneca, grants and non-financial support from Boehringer Ingelheim, grants from Chiesi Pharmaceuticals, grants and non-financial support from GSK, grants from Novartis, grants from MundiPharma, grants from TEVA, from null, outside the submitted work; and Janwillem Kocks holds 72.5% of shares in the General Practitioners Research Institute.
Conflict of interest: Dr. Vagheggini has nothing to disclose.
Conflict of interest: Dr. Poberezhets has nothing to disclose.
Conflict of interest: Dr. VOGIATZIS has nothing to disclose.
Conflict of interest: Prof. Dr. Pinnock has nothing to disclose.
Conflict of interest: Dr. Vanfleteren reports grants and personal fees from AstraZeneca, personal fees from Novartis, GSK, Chiesi, Menarini, Pulmonx, Resmed, Boehringer, Verona Pharma, AGA Linde outside the submitted work.
Conflict of interest: Dr. Abascal-Bolado has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received November 11, 2020.
- Accepted November 20, 2020.
- Copyright ©ERS 2021
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.